Physician

Kellie D Schmeeckle, M.D.

According to 2025 Medicare claims, Kellie Schmeeckle, M.D. (NPI: 1376761783) practices hematology/oncology in the Baton Rouge, LA market, with the plurality of this provider's patient population coming from E. Baton Rouge, LA. This provider's primary affiliated billing organization is MARY BIRD PERKINS CANCER CENTER (NPI: 1295833580; TIN: 237010520) and primary practice location at 70809-3482.

Schmeeckle's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 186 traditional Medicare patients, billed 25,438 HCPCS/CPT codes, and received $326,272 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 842 prescription claims across 120 beneficiaries totaling $2,692,737 in drug costs, led by Tasigna (Nilotinib Hcl). DME data shows 11 claims. Open Payments data shows 53 records totaling $995. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $68,525 to $326,272. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,066,121 to $2,692,737. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$502K$1.0M2015 Medicare payment: $68,525 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $68,642 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $66,921 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $56,783 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $58,131 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $41,014 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $52,845 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,004,944 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $658,539 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $326,272 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153551,243$68,525
20163431,307$68,642
20173361,094$66,921
2018312980$56,783
2019305937$58,131
2020255669$41,014
2021198564$52,845
202221962,700$1,004,944
202321745,015$658,539
202418625,438$326,272

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.4M$2.7M2015 Drug cost: $1,066,121 (USD; Tot_Drug_Cst)2016 Drug cost: $1,495,153 (USD; Tot_Drug_Cst)2017 Drug cost: $1,090,256 (USD; Tot_Drug_Cst)2018 Drug cost: $1,416,861 (USD; Tot_Drug_Cst)2019 Drug cost: $1,143,746 (USD; Tot_Drug_Cst)2020 Drug cost: $1,527,894 (USD; Tot_Drug_Cst)2021 Drug cost: $1,903,099 (USD; Tot_Drug_Cst)2022 Drug cost: $2,101,324 (USD; Tot_Drug_Cst)2023 Drug cost: $2,735,983 (USD; Tot_Drug_Cst)2024 Drug cost: $2,692,737 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152041,151$1,066,121
20162031,316$1,495,153
20171951,177$1,090,256
20181881,050$1,416,861
2019199980$1,143,746
20202231,139$1,527,894
20212051,053$1,903,099
20221751,072$2,101,324
20231631,011$2,735,983
2024120842$2,692,737

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$5.3K$11K2016 Medicare payment: $10,492 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $751 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,005 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $10,552 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $138 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R12$10,492
2017N/RN/RN/R
2018N/R23$751
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/R31$1,005
2023N/R36$10,552
2024N/R11$138

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more39113$128
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more72160$84
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5062$55
96375Injection of additional new drug or substance into vein2160$11
J1100Injection, dexamethasone sodium phosphate, 1 mg21490$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TasignaNilotinib Hcl26728$507,417
JakafiRuxolitinib Phosphate24720$418,115
BrukinsaZanubrutinib26780$393,037
IbrancePalbociclib20567$322,468
CabometyxCabozantinib S-Malate11330$251,601

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R11$138

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.53$995Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kellie D. Schmeeckle, M.D.?

Tedicare shows public-source Medicare data for Kellie D. Schmeeckle, M.D. (NPI 1376761783), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kellie D. Schmeeckle, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kellie D. Schmeeckle, M.D.?

Kellie D. Schmeeckle, M.D. is linked to MARY BIRD PERKINS CANCER CENTER (billing NPI 1295833580) in the available physician profile data.

Does Kellie D. Schmeeckle, M.D. have Open Payments data?

Kellie D. Schmeeckle, M.D. has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.